Current status and trends in the treatment of hemophilic patients with inhibitors.
D000906:Antibodies / Q000032:analysis; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001803:Blood Transfusion; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010956:Plasmapheresis; D017713:Platelet Transfusion; D014842:von Willebrand Diseases / Q000276:immunology / Q000628:therapy
D000906:Antibodies; D001779:Blood Coagulation Factors; D007166:Immunosuppressive Agents; C025667:prothrombin complex concentrates; D005169:Factor VIII